Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in MGNX — Macrogenics Inc

CIK 1446194 BALA CYNWYD, PA
Back to MGNX Full portfolio

Position in MGNX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$247,719
-$1,059,217 QoQ
Shares Held
53,619
-88.1% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 122 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MGNX Over Time

Shares Held

Position Value (USD)

Derivatives in MGNX

reported options exposure · as of Jun 30, 2026
CallValue
$107,184
CallShares
23,200
PutValue
$81,774
PutShares
17,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. MGNX ranks #215 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in MGNX

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $107,184 23,200
2026-06-30 $81,774 17,700
2026-06-30 $247,719 53,619
2026-03-31 $134,674 46,600
2026-03-31 $1,306,936 452,227
2026-03-31 $40,460 14,000
2025-12-31 $21,252 13,200
2025-12-31 $110,350 68,541
2025-09-30 $111,888 66,600
2025-09-30 $59,976 35,700
2025-09-30 $375,972 223,793
2025-06-30 $237,916 196,625
2025-06-30 $24,684 20,400
2025-06-30 $25,531 21,100
2025-03-31 $51,943 40,900
2025-03-31 $143,380 112,898
2025-03-31 $15,113 11,900
2024-12-31 $249,678 76,824
2024-12-31 $100,425 30,900
2024-09-30 $134,890 41,000
2024-09-30 $135,877 41,300
2024-09-30 $157,534 47,883
2024-06-30 $226,525 53,300
2024-06-30 $433,869 102,087
2024-06-30 $169,150 39,800
2024-03-31 $1,448,448 98,400
2024-03-31 $710,976 48,300
2024-03-31 $7,829,891 531,922
2023-12-31 $771,735 80,222
2023-12-31 $183,742 19,100
2023-09-30 $76,890 16,500
2023-09-30 $851,852 182,801
2023-06-30 $1,521,143 284,326
2023-06-30 $292,645 54,700
2023-03-31 $2,202,537 307,188
2023-03-31 $548,505 76,500
2022-12-31 $498,700 74,322
2022-09-30 $36,676 10,600
2022-09-30 $127,763 36,926
2022-06-30 $273,703 92,781
2022-03-31 $505,297 57,355
2021-12-31 $279,270 17,400
2021-12-31 $1,560,990 97,258
2021-12-31 $426,930 26,600
2021-09-30 $207,306 9,900
2021-09-30 $971,616 46,400
2021-09-30 $1,888,620 90,192
2021-06-30 $1,614,044 60,091
2021-06-30 $1,160,352 43,200
2021-06-30 $1,171,096 43,600